Page last updated: 2024-11-05

tulobuterol and Congenital Myasthenia

tulobuterol has been researched along with Congenital Myasthenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Miyana, K1
Ishiyama, A1
Saito, Y1
Nishino, I1

Other Studies

1 other study available for tulobuterol and Congenital Myasthenia

ArticleYear
Tulobuterol is a potential therapeutic drug in congenital myasthenic syndrome.
    Pediatrics international : official journal of the Japan Pediatric Society, 2022, Volume: 64, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Humans; Myasthenic Syndromes, Congenital; Terbutaline

2022